IOI OLEO GMBH

Abstract The oral bioavailability of marketed ivermectin (IVR) tablets is 50% compared to an oral hydroalcoholic solution. In this study,...

Abstract Berberine, known as an antioxidant agent, can improve glycemic indices in animal models of diabetes; however, it is clinically...

Abstract Colloidal lignin particles (CLPs) are emerging as eco-friendly alternatives to molecular fossil-based emulsifiers, also offering an effective way to...

Abstract Introduction This study explores the emulsification behavior and oral delivery performance of dry and wet inverted lipid phases (ILPdry and...

Abstract The use of clinically important antibiotics in U.S. poultry production has decreased drastically over the past decade. They can...

IOI Oleo PRESS RELEASE Film-formers are the unsung heroes in cosmetics. They play a critical role enabling long wear, water...

PRESS RELEASE, 21. August 2025 From 2027, the cosmetics industry will be entering a new chapter: cyclopentasiloxane and other cyclic...

PRESS RELEASE, 18. September 2025 When a challenge becomes an opportunity In the world of pharmaceutical development, there is a constantly...

CPhI Frankfurt 2025 Review IOI Oleo´s  innovative polyglycerol esters now have a name – We’re thrilled to introduce LipoGalen™ as...

Abstract Background/Objectives: PEGylated zein nanoparticles (PZNs) loaded with losartan potassium (LOS) were developed as a repurposed treatment for vaginal methicillin-resistant Staphylococcus aureus (MRSA) infection....